Skip to main content

Birchview Capital, LP

Position in ALKS — Alkermes plc.

CIK 1618205 BURLINGTON, VT

Position in ALKS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,768,000
+$369,000 QoQ
Shares Held
50,000
0.0% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Birchview Capital, LP holds $8,864,660 across 4 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (19.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ALKS
Alkermes plc.
This page
50,000 $1,768,000

All Filings in ALKS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,768,000 50,000
2025-12-31 $1,399,000 50,000
2025-09-30 $1,500,000 50,000
2025-06-30 $1,430,500 50,000
2025-03-31 $1,651,000 50,000
2024-12-31 $1,438,000 50,000
2024-09-30 $1,399,500 50,000
2024-06-30 $1,205,000 50,000
2024-03-31 $1,353,500 50,000
2023-12-31 $1,387,000 50,000
2023-09-30 $1,400,500 50,000
2023-06-30 $1,565,000 50,000
2023-03-31 $1,409,500 50,000
2022-12-31 $1,306,500 50,000
2022-09-30 $1,116,500 50,000
2022-06-30 $1,489,500 50,000
2022-03-31 $1,315,500 50,000
2021-12-31 $1,163,000 50,000
2021-09-30 $1,542,000 50,000
2021-06-30 $1,226,000 50,000
2021-03-31 $653,800 35,000